Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice M Hodnefield

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Journal of Clinical Pathology|September 19, 2013
IgM multiple myeloma: pathologic evaluation of a rare entityRebecca L King, Matthew T Howard, Janice M Hodnefield, et al.
American Journal of Clinical Pathology|July 27, 2004
An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10William G Morice, Janice M Hodnefield, Paul J Kurtin, et al.
Leukemia Research|January 23, 2003
Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?David P Steensma, Gordon W Dewald, Janice M Hodnefield, et al.
Seminars in Oncology|April 30, 2003
Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cellsEllen D Remstein, Curtis A Hanson, Robert A Kyle, et al.
Leukemia Research|June 28, 2011
The significance of isolated Y chromosome loss in bone marrow metaphase cells from males over age 50 yearsAnne E Wiktor, Daniel L Van Dyke, Janice M Hodnefield, et al.
Leukemia Research|January 17, 2002
Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISHRhett P Ketterling, William A Wyatt, Scott A VanWier, et al.
Mayo Clinic Proceedings|July 11, 2008
Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patientsWilliam G Morice, Paul J Kurtin, Janice M Hodnefield, et al.
Blood|April 28, 2012
Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blastsMrinal M Patnaik, Curtis A Hanson, Nanna H Sulai, et al.
American Journal of Hematology|May 21, 2013
Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromesNaseema Gangat, Mrinal M Patnaik, Kebede Begna, et al.
American Journal of Hematology|January 22, 2013
Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevanceMrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Clinical Pathology|September 19, 2013
IgM multiple myeloma: pathologic evaluation of a rare entityRebecca L King, Matthew T Howard, Janice M Hodnefield, et al.
American Journal of Clinical Pathology|July 27, 2004
An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10William G Morice, Janice M Hodnefield, Paul J Kurtin, et al.
Leukemia Research|January 23, 2003
Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?David P Steensma, Gordon W Dewald, Janice M Hodnefield, et al.
Seminars in Oncology|April 30, 2003
Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cellsEllen D Remstein, Curtis A Hanson, Robert A Kyle, et al.
Leukemia Research|June 28, 2011
The significance of isolated Y chromosome loss in bone marrow metaphase cells from males over age 50 yearsAnne E Wiktor, Daniel L Van Dyke, Janice M Hodnefield, et al.
Leukemia Research|January 17, 2002
Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISHRhett P Ketterling, William A Wyatt, Scott A VanWier, et al.
Mayo Clinic Proceedings|July 11, 2008
Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patientsWilliam G Morice, Paul J Kurtin, Janice M Hodnefield, et al.
Blood|April 28, 2012
Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blastsMrinal M Patnaik, Curtis A Hanson, Nanna H Sulai, et al.
American Journal of Hematology|May 21, 2013
Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromesNaseema Gangat, Mrinal M Patnaik, Kebede Begna, et al.
American Journal of Hematology|January 22, 2013
Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevanceMrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.
Pageof 2